Rafael Holdings, Inc. (NYSE:RFL - Get Free Report) CEO Howard S. Jonas acquired 13,080,457 shares of the stock in a transaction that occurred on Thursday, June 5th. The stock was purchased at an average price of $1.28 per share, with a total value of $16,742,984.96. Following the completion of the transaction, the chief executive officer now owns 12,299,207 shares of the company's stock, valued at approximately $15,742,984.96. This trade represents a -1,674.30% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Rafael Price Performance
Shares of Rafael stock traded up $0.13 during trading on Thursday, hitting $2.19. 492,238 shares of the company were exchanged, compared to its average volume of 71,990. The firm has a market capitalization of $54.56 million, a P/E ratio of -1.31 and a beta of 0.91. Rafael Holdings, Inc. has a 1-year low of $1.28 and a 1-year high of $3.19. The firm's fifty day moving average price is $1.59 and its 200 day moving average price is $1.81.
Rafael (NYSE:RFL - Get Free Report) last issued its quarterly earnings data on Wednesday, June 11th. The company reported ($0.19) earnings per share (EPS) for the quarter. Rafael had a negative net margin of 5,707.03% and a negative return on equity of 53.71%. The business had revenue of $0.36 million during the quarter.
Institutional Investors Weigh In On Rafael
Large investors have recently made changes to their positions in the stock. Peapod Lane Capital LLC bought a new stake in Rafael in the 4th quarter valued at $553,000. Geode Capital Management LLC increased its position in shares of Rafael by 17.9% in the fourth quarter. Geode Capital Management LLC now owns 174,561 shares of the company's stock worth $288,000 after purchasing an additional 26,493 shares during the period. Wealth Enhancement Advisory Services LLC bought a new position in shares of Rafael in the first quarter worth $26,000. Finally, Ieq Capital LLC acquired a new stake in Rafael in the first quarter valued at about $447,000. Institutional investors and hedge funds own 11.30% of the company's stock.
About Rafael
(
Get Free Report)
Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.
Recommended Stories
Before you consider Rafael, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rafael wasn't on the list.
While Rafael currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
